Major Interest in Shares

For Immediate Release

24 March 2009

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached

Futura Medical PLC

2. Reason for the notification 

An event changing the breakdown of voting rights

YES

3. Full name of person(s) subject to the notification obligation:

Brookwell Limited

4. Full name of shareholder(s) (if different from 3.)

Nortrust Nominees Limited

5. Date of the transaction (and date on which the threshold is crossed or reached if different)

6 March 2009

6. Date on which issuer notified:

24 March 2009

7. Threshold(s) that is/are crossed or reached:

>7% to >6%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares 

if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Resulting situation after the triggering transaction

Number of Shares 

Number of Voting Rights 

Number of shares 

Number of voting rights 

% of voting rights

Direct

Direct 

Indirect 

Direct

Indirect

Ordinary Shares

GB0033278473

4,133,835

4,133,835

4,133,835

4,133,835

-

6.60%

-

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

None

Total (A+B)

Number of voting rights

Percentage of voting rights

4,133,835

6.60%

Additional Information 

Progressive AIM Realisation Limited is Investment Manager to Brookwell Limited

Contact name 

Russell Scott

Contact telephone number 

020 7490 4355

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

mail to: [email protected]

www.futuramedical.co.uk 

Canaccord Adams

Ryan Gaffney / Adria Da Breo Richards

Tel: +44 (0) 20 7050 6500 

For media enquiries please contact: 

Buchanan Communications

Mark Court / Rebecca Skye Dietrich / Stasa Filiplic

Tel: +44 (0) 20 7466 5000